compounding
Articles tagged with “compounding”
TMS vs. Ketamine: What TRD Patients Should Know
Medical Daily covers when to try ketamine or TMS for treatment-resistant depression. Here's what it means for patients weighing ketamine troches.
IV Ketamine in the News: What Troche Users Should Know
A FOX 4 Kansas City segment spotlights IV ketamine therapy. Here's what the growing media attention means for ketamine troche patients and at-home access.
Esketamine Clinic Protocols: What Troche Patients Should Know
New guidance on esketamine clinical setup highlights why ketamine troches remain a flexible, accessible alternative for many treatment-resistant depression patients.
Ketamine Dropout Rates: The Case for Troche Optimization
New clinical data on NMDA antagonist side effects and dropout rates reveals why troche dosing flexibility may improve long-term treatment adherence.
Trump EO Could Reshape Ketamine Troche Access in 2026
President Trump's 2026 executive order on psychedelic research signals a regulatory shift that could affect compounded ketamine troche access and prescribing.
FDA Review of Preservative-Free Ketamine Advances
NRx Pharmaceuticals reports progress on FDA review of its preservative-free ketamine application. Here's what it could mean for troche access and compounding.
NRx's FDA Push for Preservative-Free Ketamine Explained
NRx Pharmaceuticals reports FDA progress on a preservative-free ketamine application. Here's what it means for troche access, compounding, and home dosing.
NMDA Side Effects: What Troche Users Need to Know
New clinical data on NMDA receptor antagonist side effects and dropout rates—and what it means for ketamine troche dosing and monitoring routines.
Insurance Gaps Push Patients to Ketamine Access Funds
Most insurers still deny ketamine coverage for depression. Learn how patient assistance programs are bridging the gap and what it means for troche access.
Esketamine vs. Troches: What TRD Patients Should Know
A new clinical review on esketamine for TRD highlights access barriers and patient preferences — here's what it means for ketamine troche therapy.
France Approves IV Ketamine for Suicidal Crisis: What It Means
France has approved IV ketamine for acute suicidal crises. Here's what this global shift means for ketamine troche patients and at-home treatment access in the U.S.
Glutamate Pathways Are Reshaping TRD Treatment
A 2026 review highlights how glutamate-targeting drugs like esketamine and ketamine troches are redefining treatment-resistant depression care.
Glutamate Pathway Treatments Reshape TRD Care
New research highlights glutamate-based treatments for treatment-resistant depression. Here's what it means for ketamine troche patients in 2026.
Compounded vs. Commercial Ketamine Troches: Understanding the Difference
Explaining the difference between custom compounded ketamine troches and commercially manufactured products — covering quality standards, regulation, cost, consistency, and what patients should know.
How Ketamine Troches Are Made: The Compounding Process
A look inside the compounding pharmacy process that creates ketamine troches — from raw pharmaceutical ingredients to the finished lozenge that arrives at your door.
Troche vs. Lozenge: Is There a Difference?
Many patients wonder whether a troche and a lozenge are the same thing. Learn the technical distinction, why the terminology matters, and what it means for your ketamine prescription.
How to Store Ketamine Troches: Refrigeration, Shelf Life, and Safety
Do ketamine troches need refrigeration? Learn proper storage conditions, shelf life expectations, and how to keep your troches potent and safe.
Ketamine Troches vs. RDT Wafers: Understanding the Differences
Ketamine troches and rapidly dissolving tablet (RDT) wafers are both oral ketamine formats but differ in formulation, dissolution, and absorption. Learn the key distinctions.
Active Ingredients in Ketamine Troches
Ketamine troches contain ketamine HCl as the active ingredient, plus excipients like PEG base, flavoring, and preservatives. Learn what's in your compounded troche and why it matters.
FDA Status of Compounded Ketamine Troches
Compounded ketamine troches are not FDA-approved but are legal under 503A compounding law. Understand prescriber liability, regulatory status, and what this means for patients.
How to Store Ketamine Troches
Proper storage of ketamine troches preserves potency and safety. Learn about temperature, humidity, light exposure, and the refrigeration debate for compounded lozenges.
How Are Ketamine Troches Compounded?
Learn how compounding pharmacies make ketamine troches, the ingredients used, quality standards followed, and what makes one pharmacy better than another.
What Is a Ketamine Troche?
A ketamine troche is a sublingual lozenge prescribed for depression and pain. Learn how it's made, how it works, and why doctors prescribe it.
Contact Ketamine Troche
Send corrections, provider questions, or advertising inquiries.